Chief acknowledges overstating treatment effect.
The Food and Drug Administration announced that it had gone too far in promoting the treatment effects of convalescent plasma in fighting against COVID-19 after feedback from medical professionals. FDA Commissioner Stephen Hahn had initially stated that 35 out of 100 people would survive COVID-19 if they received the transfusion – a claim supported by President Trump.
Commissioner Hahn said, “I have been criticized for remarks I made Sunday night about the benefits of convalescent plasma. The criticism is entirely justified. What I should have said better is that the data show a relative risk reduction, not an absolute risk reduction.” The 35% figure cannot be substantiated due to no control group being used in the studying of the treatment.
As the Lord Leads, Pray with Us…
- For God to lead the president’s administration to find the best cures for COVID-19.
- That the FDA would approve proven cures for COVID-19.
- For Commissioner Hahn to be given wisdom from above on how to fight the pandemic.
Sources: AP, CNN, NPR
